NRG-HN014 / TD 24.02: Randomized Phase III Trial of Peri-operative Immunotherapy with Response-adjusted Surgery versus Standard-of-Care (SOC) Surgery for Resectable Stage III/IV Cutaneous Squamous Cell Carcinoma (CSCC) (Cat B, NewProposal) (#49)
Peter MacCallam Cancer Centre, Melbourne, VIC, Australia
NRG-HN014 / TD 24.02: Randomized Phase III Trial of Peri-operative Immunotherapy with Response-adjusted Surgery versus Standard-of-Care (SOC) Surgery for Resectable Stage III/IV Cutaneous Squamous Cell Carcinoma (CSCC) (Cat B, NewProposal)